Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 123
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Oral Dis ; 29(2): 574-583, 2023 Mar.
Article in English | MEDLINE | ID: mdl-34337826

ABSTRACT

OBJECTIVE: This study was conducted to investigate key long noncoding RNAs (lncRNAs) involved in competitive endogenous RNA (ceRNA) network associated with laryngeal squamous cell carcinoma (LSCC). MATERIALS AND METHODS: Three mRNA datasets, two miRNA datasets, and one lncRNA dataset of LSCC were downloaded from GEO database. Following the identification of differentially expressed mRNAs (DEmRNAs), (microRNAs) miRNAs (DEmiRNAs), and lncRNAs (DElncRNAs) in LSCC compared with adjacent tissues, functional enrichment of DEmRNAs was performed. Then, construction of the ceRNA (DElncRNA-DEmiRNA-DEmRNA) regulatory network and functional analyses of all DEmRNAs in ceRNA regulatory network were conducted. Quantitative real-time polymerase chain reactions (qRT-PCR) were used to detect the expression levels of selected DEmRNAs, DEmiRNAs, and DElncRNAs. RESULTS: A total of 3449 DEmRNAs, 40 DEmiRNAs, and 100 DElncRNAs were identified in LSCC. The ceRNA networks, which contained 132 DElncRNA-DEmiRNA pairs and 287 DEmiRNA-DEmRNA pairs, involving 44 lncRNAs, 3 miRNAs, and 271 mRNAs, were obtained. DEmRNAs in ceRNA regulatory networks were significantly enriched in pathways in cancer, prostate cancer, and aldosterone-regulated sodium reabsorption. Except for HCG22 and hsa-miR-1246, expressions of the others in the qRT-PCR results played the same pattern with that in our integrated analysis, generally. CONCLUSIONS: We concluded that HCG22/EGOT-hsa-miR-1275-FAM107A and HCG22/EGOT-hsa-miR-1246-Glycerol-3-phosphate dehydrogenase 1 like interaction pairs may play a central role in LSCC.


Subject(s)
Head and Neck Neoplasms , MicroRNAs , RNA, Long Noncoding , Male , Humans , Squamous Cell Carcinoma of Head and Neck/genetics , RNA, Long Noncoding/genetics , Gene Regulatory Networks , MicroRNAs/genetics , MicroRNAs/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Head and Neck Neoplasms/genetics , Gene Expression Regulation, Neoplastic/genetics
2.
Ecotoxicol Environ Saf ; 268: 115684, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37976935

ABSTRACT

The extensive use of carbamate pesticides has led to a range of environmental and health problems, such as surface and groundwater contamination, and endocrine disorders in organisms. In this study, we focused on examining the effects of toxic exposure to the carbamate pesticide methomyl on the hatching, morphology, immunity and developmental gene expression levels in zebrafish embryos. Four concentrations of methomyl (0, 2, 20, and 200 µg/L) were administered to zebrafish embryos for a period of 96 h. The study found that exposure to methomyl accelerated the hatching process of zebrafish embryos, with the strongest effect recorded at the concentration of 2 µg/L. Methomyl exposure also trigged significantly reductions in heart rate and caused abnormalities in larvae morphology, and it also stimulated the synthesis and release of several inflammatory factors such as IL-1ß, IL-6, TNF-α and INF-α, lowered the IgM contents, ultimately enhancing inflammatory response and interfering with immune function. All of these showed the significant effects on exposure time, concentration and their interaction (Time × Concentration). Furthermore, the body length of zebrafish exposed to methomyl for 96 h was significantly shorter, particularly at higher concentrations (200 µg/L). Methomyl also affected the expression levels of genes associated with development (down-regulated igf1, bmp2b, vasa, dazl and piwi genes), demonstrating strong developmental toxicity and disruption of the endocrine system, with the most observed at the concentration of 200 µg/L and 96 h exposure to methomyl. The results of this study provide valuable reference information on the potential damage of methomyl concentrations in the environment on fish embryo development, while also supplementing present research on the immunotoxicity of methomyl.


Subject(s)
Pesticides , Water Pollutants, Chemical , Animals , Zebrafish/metabolism , Methomyl/metabolism , Methomyl/pharmacology , Embryo, Nonmammalian , Endocrine System , Pesticides/metabolism , Carbamates/metabolism , Larva , Water Pollutants, Chemical/metabolism
3.
Genome ; 64(11): 969-984, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33901411

ABSTRACT

MicroRNAs (miRNAs) are small, non-coding, regulatory RNAs that play important roles in abiotic stress responses in plants, but their regulatory roles in the adaptive response to heat stress at the booting stage in two rice varieties, 9311 and Nagina 22, remain largely unknown. In this study, 464 known miRNAs and 123 potential novel miRNAs were identified. Of these miRNAs, a total of 90 differentially expressed miRNAs were obtained with 9311 libraries as the control group, of which 54 were upregulated and 36 were downregulated. To gain insight into functional significance, 2773 potential target genes of these 90 differentially expressed miRNAs were predicted. GO enrichment analysis showed that the predicted target genes of differentially expressed miRNAs included NACs, LACs, CSD, and Hsp40. KEGG pathway analysis showed that the target genes of these differentially expressed miRNAs were significantly enriched in the plant hormone signal transduction pathway. The expression levels of 10 differentially expressed miRNAs and their target genes obtained by qRT-PCR were largely consistent with the sequencing results. This study lays a foundation for the elucidation of the miRNA-mediated regulatory mechanisms in rice at elevated temperatures.


Subject(s)
MicroRNAs , Oryza , Stress, Physiological , Temperature , Gene Expression Profiling , Gene Expression Regulation, Plant , High-Throughput Nucleotide Sequencing , MicroRNAs/genetics , Oryza/genetics , RNA, Plant/genetics , Sequence Analysis, RNA
4.
Int J Mol Sci ; 22(18)2021 Sep 18.
Article in English | MEDLINE | ID: mdl-34576264

ABSTRACT

After the discovery of endogenous dinitrosyl iron complexes (DNICs) as a potential biological equivalent of nitric oxide (NO), bioinorganic engineering of [Fe(NO)2] unit has emerged to develop biomimetic DNICs [(NO)2Fe(L)2] as a chemical biology tool for controlled delivery of NO. For example, water-soluble DNIC [Fe2(µ-SCH2CH2OH)2(NO)4] (DNIC-1) was explored for oral delivery of NO to the brain and for the activation of hippocampal neurogenesis. However, the kinetics and mechanism for cellular uptake and intracellular release of NO, as well as the biocompatibility of synthetic DNICs, remain elusive. Prompted by the potential application of NO to dermato-physiological regulations, in this study, cellular uptake and intracellular delivery of DNIC [Fe2(µ-SCH2CH2COOH)2(NO)4] (DNIC-2) and its regulatory effect/biocompatibility toward epidermal cells were investigated. Upon the treatment of DNIC-2 to human fibroblast cells, cellular uptake of DNIC-2 followed by transformation into protein-bound DNICs occur to trigger the intracellular release of NO with a half-life of 1.8 ± 0.2 h. As opposed to the burst release of extracellular NO from diethylamine NONOate (DEANO), the cell-penetrating nature of DNIC-2 rationalizes its overwhelming efficacy for intracellular delivery of NO. Moreover, NO-delivery DNIC-2 can regulate cell proliferation, accelerate wound healing, and enhance the deposition of collagen in human fibroblast cells. Based on the in vitro and in vivo biocompatibility evaluation, biocompatible DNIC-2 holds the potential to be a novel active ingredient for skincare products.


Subject(s)
Biocompatible Materials/chemistry , Fibroblasts/drug effects , Iron/chemistry , Nitric Oxide/chemistry , Nitrogen Oxides/chemistry , Skin/drug effects , Animals , Cell Line , Cell Movement , Cell Proliferation , Cell Survival , Collagen/chemistry , Cornea/drug effects , Drug Delivery Systems , Embryo, Nonmammalian/drug effects , Epithelium/drug effects , Eye/drug effects , Fibroblasts/metabolism , Humans , In Vitro Techniques , Kinetics , Melanocytes/metabolism , Oxygen/chemistry , Pigmentation , Wound Healing , Zebrafish/embryology
5.
Synapse ; 71(2)2017 02.
Article in English | MEDLINE | ID: mdl-27733018

ABSTRACT

PURPOSE: Lamotrigine (LTG) is a broad-spectrum antiepileptic drug that is widely used in clinic. However, the effect of LTG on cognition and neurodegeneration during epilepsy treatment remains controversial. In this study, we compared the cognitive effects of LTG and sodium valproate in pentylenetetrazole (PTZ)-kindled animal model, and the dose dependency was tested for LTG. METHODS: PTZ-kindled animals were divided into the following treatment groups: control group, treated with 3.5 mL/kg of 0.9% sodium chloride; low-dose LTG group, treated with 12.5 mg/kg of LTG; middle-dose LTG group, treated with 25 mg/kg of LTG; high-dose LTG group, treated with 50 mg/kg of LTG; VPA group, treated with 300 mg/kg of VPA. The Morris Water Maze (MWM) test commenced from the 10th day of treatment. Hippocampal cell apoptosis was determined by TUNEL staining after two weeks of treatment. RESULTS: Compared to the vehicle-treated control group, escape latency was significantly reduced in the middle- and high-dose LTG- and VPA-treated groups on the 3rd and 4th day of the MWM test (p < .05), and spatial probe frequency was significantly improved in the middle- and high-dose LTG- and VPA-treated groups (p < .05). Furthermore, the immunohistochemical score of TUNEL positive cells significantly decreased in the hippocampal CA1 region in the middle- and high-dose LTG- and VPA-treated groups (p < .05). CONCLUSION: Our data suggests that LTG may ameliorate epilepsy-induced cognitive impairment and neuronal cell apoptosis during epilepsy treatment. LTG may ameliorate cognitive impairment and neuronal cell apoptosis during epilepsy treatment.


Subject(s)
Anticonvulsants/therapeutic use , Apoptosis , CA1 Region, Hippocampal/drug effects , Cognitive Dysfunction/drug therapy , Epilepsy/drug therapy , Triazines/therapeutic use , Animals , Anticonvulsants/administration & dosage , Anticonvulsants/pharmacology , CA1 Region, Hippocampal/pathology , CA1 Region, Hippocampal/physiopathology , Cognitive Dysfunction/etiology , Epilepsy/etiology , Female , Lamotrigine , Maze Learning , Pentylenetetrazole/toxicity , Rats , Rats, Sprague-Dawley , Triazines/administration & dosage , Triazines/pharmacology
6.
Pediatr Res ; 80(3): 371-81, 2016 09.
Article in English | MEDLINE | ID: mdl-27119313

ABSTRACT

BACKGROUND: The pathogenicity of copy number variations (CNV) in neurodevelopmental disorders is supported by research literature. However, few studies have evaluated the utility and counseling challenges of CNV analysis in clinic. METHODS: We analyzed the findings of CNV studies from a cohort referred for genetics evaluation of autism spectrum disorders (ASD), developmental disability (DD), and intellectual disability (ID). RESULTS: Twenty-two CNV in 21 out of 115 probands are considered to be pathogenic (18.3%). Five CNV are likely pathogenic and 22 CNV are variants of unknown significance (VUS). We have found seven cases with more than two CNV and two with a complex rearrangement of the 22q13.3 Phelan-McDermid syndrome region. We identified a new and de novo 1q21.3 deletion that encompasses SETDB1, a gene encoding methylates histone H3 on lysine-9 (H3K9) methyltransferase, in a case with ASD. CONCLUSION: We provide evidence to support the value of CNV analysis in etiological evaluation of neurodevelopmental disorders in autism genetics clinic. However, interpretation of the clinical significance and counseling families are still challenging because of the variable penetrance and pleotropic expressivity of CNV. In addition, the identification of a 1q21.3 deletion encompassing SETDB1 provides further support for the role of chromatin modifiers in the etiology of ASD.


Subject(s)
Microarray Analysis , Neurodevelopmental Disorders/genetics , Protein Methyltransferases/genetics , Adolescent , Algorithms , Autistic Disorder/genetics , Child , Child, Preschool , Chromatin/metabolism , Comparative Genomic Hybridization , Counseling , DNA Copy Number Variations , Developmental Disabilities/genetics , Female , Gene Deletion , Gene Rearrangement , Histone-Lysine N-Methyltransferase , Humans , Infant , Intellectual Disability/genetics , Male , Pedigree
7.
Epilepsy Behav ; 57(Pt A): 177-184, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26967006

ABSTRACT

Most antiepileptic drugs (AEDs) interfere with cognitive function, and there is therefore an urgent need for AEDs that are effective but do not have this side effect. Various studies have reported the antiinflammatory and cytoprotective properties of the natural flavonoid luteolin (LU); however, none has examined systematically its antiseizure potential. The current study investigated the effects of LU on pentylenetetrazole (PTZ)-induced cognitive impairment in rats and the underlying mechanisms. Seizures were induced in rats by daily injection of PTZ for 36 days. Two other groups were pretreated with LU (50 or 100 mg/kg/day by oral administration) 30 min prior to PTZ administration. Seizure severity was scored, and cognitive function was tested in the Morris water maze. Neuronal damage, mitochondrial generation of reactive oxygen species, oxidative stress, phosphoactivation of the protein kinase A (PKA)-cyclic AMP response element-binding protein (CREB) pathway, and brain-derived neurotrophic factor (BDNF) expression were measured in the hippocampus. Pretreatment with LU suppressed seizure induction, duration, and severity following PTZ injection, reversed cognitive impairment, reduced neuronal and oxidative stress damage, and increased phosphoactivation of PKA and CREB as well as BDNF expression. These results indicate that LU should be further investigated as a treatment for epilepsy.


Subject(s)
Cognition/drug effects , Cognitive Dysfunction/drug therapy , Luteolin/pharmacology , Oxidative Stress/drug effects , Pentylenetetrazole/adverse effects , Animals , Anticonvulsants/therapeutic use , Brain/drug effects , Brain/metabolism , Brain-Derived Neurotrophic Factor , Cognitive Dysfunction/psychology , Convulsants/toxicity , Cyclic AMP Response Element-Binding Protein , Cyclic AMP Response Element-Binding Protein A , Epilepsy/drug therapy , Male , Protein Kinases/metabolism , Rats , Seizures/chemically induced , Signal Transduction/drug effects
8.
Acta Pharmacol Sin ; 37(1): 34-43, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26657056

ABSTRACT

Ion channels are involved in a variety of fundamental physiological processes, and their malfunction causes numerous human diseases. Therefore, ion channels represent a class of attractive drug targets and a class of important off-targets for in vitro pharmacological profiling. In the past decades, the rapid progress in developing functional assays and instrumentation has enabled high throughput screening (HTS) campaigns on an expanding list of channel types. Chronologically, HTS methods for ion channels include the ligand binding assay, flux-based assay, fluorescence-based assay, and automated electrophysiological assay. In this review we summarize the current HTS technologies for different ion channel classes and their applications.


Subject(s)
High-Throughput Screening Assays/methods , Ion Channels/metabolism , Animals , Drug Design , Humans
9.
Acta Pharmacol Sin ; 37(9): 1190-8, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27397543

ABSTRACT

AIM: Recent studies have shown that the two-pore-domain potassium channel TREK-1 is involved in the proliferation of neural stem cells, astrocytes and human osteoblasts. In this study, we investigated how TREK-1 affected the proliferation of Chinese hamster ovary (CHO) cells in vitro. METHODS: A CHO cell line stably expressing hTREK-1 (CHO/hTREK-1 cells) was generated. TREK-1 channel currents in the cells were recorded using whole-cell voltage-clamp recording. The cell cycle distribution was assessed using flow cytometry analysis. The expression of major signaling proteins involved was detected with Western blotting. RESULTS: CHO/hTREK-1 cells had a high level of TREK-1 expression, reached up to 320%±16% compared to the control cells. Application of arachidonic acid (10 µmol/L), chloroform (1 mmol/L) or etomidate (10 µmol/L) substantially increased TREK-1 channel currents in CHO/hTREK-1 cells. Overexpression of TREK-1 caused CHO cells arresting at the G1 phase, and significantly decreased the expression of cyclin D1. The TREK-1 inhibitor l-butylphthalide (1-100 µmol/L) dose-dependently attenuated TREK-1-induced G1 phase cell arrest. Moreover, overexpression of TREK-1 significantly decreased the phosphorylation of Akt (S473), glycogen synthase kinase-3ß (S9) and cAMP response element-binding protein (CREB, S133), enhanced the phosphorylation of p38 (T180/Y182), but did not alter the phosphorylation and expression of signal transducer and activator of transcription 3 (STAT3). CONCLUSION: TREK-1 overexpression suppresses CHO cell proliferation by inhibiting the activity of PKA and p38/MAPK signaling pathways and subsequently inducing G1 phase cell arrest.


Subject(s)
Cell Proliferation/genetics , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , G1 Phase Cell Cycle Checkpoints/genetics , Potassium Channels, Tandem Pore Domain/genetics , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , Animals , Arachidonic Acid/pharmacology , Benzofurans/pharmacology , Blotting, Western , CHO Cells , Cell Proliferation/drug effects , Chloroform/pharmacology , Cricetinae , Cricetulus , Etomidate/pharmacology , Flow Cytometry , G1 Phase Cell Cycle Checkpoints/drug effects , Humans , Membrane Potentials/drug effects , Membrane Potentials/genetics , Patch-Clamp Techniques , Potassium Channels, Tandem Pore Domain/antagonists & inhibitors , Signal Transduction , Transfection
10.
Cell Mol Life Sci ; 72(10): 2005-22, 2015 May.
Article in English | MEDLINE | ID: mdl-25504289

ABSTRACT

The regulation of cardiac differentiation is critical for maintaining normal cardiac development and function. The precise mechanisms whereby cardiac differentiation is regulated remain uncertain. Here, we have identified a GATA-4 target, EGF, which is essential for cardiogenesis and regulates cardiac differentiation in a dose- and time-dependent manner. Moreover, EGF demonstrates functional interaction with GATA-4 in inducing the cardiac differentiation of P19CL6 cells in a time- and dose-dependent manner. Biochemically, GATA-4 forms a complex with STAT3 to bind to the EGF promoter in response to EGF stimulation and cooperatively activate the EGF promoter. Functionally, the cooperation during EGF activation results in the subsequent activation of cyclin D1 expression, which partly accounts for the lack of additional induction of cardiac differentiation by the GATA-4/STAT3 complex. Thus, we propose a model in which the regulatory cascade of cardiac differentiation involves GATA-4, EGF, and cyclin D1.


Subject(s)
Cell Differentiation/physiology , Epidermal Growth Factor/metabolism , GATA4 Transcription Factor/metabolism , Heart/embryology , Models, Biological , Myocardium/cytology , Signal Transduction/physiology , Animals , Blotting, Western , Cell Line, Tumor , Chromatin Immunoprecipitation , Histological Techniques , Immunoprecipitation , Mice , Real-Time Polymerase Chain Reaction , Time Factors
11.
Yao Xue Xue Bao ; 51(5): 762-9, 2016 05.
Article in Zh | MEDLINE | ID: mdl-29874023

ABSTRACT

Fourteen new compounds with 2,3-dihydro-1H-pyrrolo[3,2-c]-quinoline or 2,3,5,9b-tetrahydro-1H-pyrrolo[3,2-c]quinoline scaffold were designed and synthesized, and their inhibitory activities against Kv2.1 were evaluated. As a result,2,3-dihydro-1H-pyrrolo[3,2-c]quinoline derivatives 3a and 5a were identified as potent inhibitors of Kv2.1 with IC(50) values of 10.2 and 9.0 µmol·L(-1), respectively.


Subject(s)
Quinolines/chemistry , Shab Potassium Channels/antagonists & inhibitors , Humans , Structure-Activity Relationship
12.
Yao Xue Xue Bao ; 51(5): 743-8, 2016 05.
Article in Zh | MEDLINE | ID: mdl-29874020

ABSTRACT

Gastrodin, parishin and parishin C were purified from a water extract of GE (rhizome of Gastrodia elata, an herb medicine for treatment of neuronal disorders). In order to compare the pharmacological effects of gastrodin, parishin and parishin C on improving cognition deficits, we tested them in an animal model of cognition disorders induced by scopolamine and in a study of in vivo long-term potentiation (LTP) recordings. In the Morris water maze task, parishin C (15 and 50 mg·kg(-1), P<0.05) and parishin (150 mg·kg(-1), P<0.05), improved spatial learning and memory significantly. However, gastrodin showed no significant effects at the dose of 150 mg·kg(-1). In vivo LTP recordings showed that parishin C at 5,10 and 20 mg·kg(-1), parishin at 10, 30 and 100 mg·kg(-1) reversed the suppression of LTP by scopolamine in rats in a dose-dependent manner. However, gastrodin at 100 mg·kg(-1) showed only a modest effect. In summary, the action of parishin C in the improvement of dementia induced by scopolamine was more potent than parishin and gastrodin.


Subject(s)
Benzyl Alcohols/pharmacology , Citrates/pharmacology , Glucosides/pharmacology , Memory Disorders/drug therapy , Spatial Learning/drug effects , Animals , Gastrodia/chemistry , Memory Disorders/chemically induced , Phytotherapy , Plant Extracts , Plants, Medicinal/chemistry , Rats , Rhizome/chemistry , Scopolamine , Structure-Activity Relationship
13.
Physiol Plant ; 154(1): 142-61, 2015 May.
Article in English | MEDLINE | ID: mdl-25270993

ABSTRACT

Seed germination is a critical phase in the plant life cycle, but the specific events associated with seed germination are still not fully understood. In this study, we used two-dimensional gel electrophoresis followed by mass spectrometry to investigate the changes in the proteome during imbibition of Oryza sativa seeds at optimal temperature with or without abscisic acid (ABA) and high temperature (germination thermoinhibition) to further identify and quantify key proteins required for seed germination. A total of 121 protein spots showed a significant change in abundance (1.5-fold increase/decrease) during germination under all conditions. Among these proteins, we found seven proteins specifically associated with seed germination including glycosyl hydrolases family 38 protein, granule-bound starch synthase 1, Os03g0842900 (putative steroleosin-B), N-carbamoylputrescine amidase, spermidine synthase 1, tubulin α-1 chain and glutelin type-A; and a total of 20 imbibition response proteins involved in energy metabolism, cell growth, cell defense and storage proteins. High temperature inhibited seed germination by decreasing the abundance of proteins involved in methionine metabolism, amino acid biosynthesis, energy metabolism, reserve degradation, protein folding and stress responses. ABA treatment inhibited germination and decreased the abundance of proteins associated with methionine metabolism, energy production and cell division. Our results show that changes in many biological processes including energy metabolism, protein synthesis and cell defense and rescue occurred as a result of all treatments, while enzymes involved in methionine metabolism and weakening of cell wall specifically accumulated when the seeds germinated at the optimal temperature.


Subject(s)
Abscisic Acid/physiology , Germination , Oryza/growth & development , Oryza/metabolism , Seeds/metabolism , Hot Temperature , Proteome , Seedlings/growth & development
14.
Guang Pu Xue Yu Guang Pu Fen Xi ; 35(5): 1243-7, 2015 May.
Article in Zh | MEDLINE | ID: mdl-26415436

ABSTRACT

Clubroot, caused by Plasmodiophora brassicae, is considered the most devastating soilborne disease in Brassica crops. It has emerged as a serious disease threatening the cruciferous crop production industry in China. Nowadays, the detection techniques for P. brassicae are laborious, time-consuming and low sensitivity. Rapid and effective detection methods are needed. The objective of this study is to develop a Fourier transform infrared spectrometer (FTIR) technique for detection of P. brassicae effectively and accurately. FTIR and Real-time PCR techniques were applied in quantitative detection of P. brassicae. Chinese cabbages were inoculated with P. brassicae. By analyzing the FTIR spectra of P. brassicae, infected clubroots and healthy roots, three specific bands 1 105, 1 145 and 1 228 cm-1 were selected. According to the correlation between the peak areas at these sensitive bands and Real-time PCR Ct value, quantitative evaluation model of P. brassicae was established based on FTIR y=34. 17 +12. 24x - 9. 81x2 - 6. 05x3, r=0. 98 (p<0. 05). To validate accuracy of the model, 10 clubroot samples were selected randomly from field, and detected by FTIR spectrum model, the results showed that the average error is 1. 60%. This demonstrated that the FTIR technology is an available one for the quantitative detection of P. brassicae in clubroot, and it provides a new method for quantitative and quickly detection of Chinese cabbage clubroot.


Subject(s)
Brassica/parasitology , Plant Diseases/parasitology , Plasmodiophorida/isolation & purification , Soil/parasitology , Spectroscopy, Fourier Transform Infrared , Crops, Agricultural/parasitology , Plant Roots/parasitology
15.
Biochem Biophys Res Commun ; 448(4): 414-7, 2014 Jun 13.
Article in English | MEDLINE | ID: mdl-24802403

ABSTRACT

Cognitive impairment, the most common and severe comorbidity of epilepsy, greatly diminishes the quality of life. However, current therapeutic interventions for epilepsy can also cause untoward cognitive effects. Thus, there is an urgent need for new kinds of agents targeting both seizures and cognition deficits. Oxidative stress is considered to play an important role in epileptogenesis and cognitive deficits, and antioxidants have a putative antiepileptic potential. Metformin, the most commonly prescribed antidiabetic oral drug, has antioxidant properties. This study was designed to evaluate the ameliorative effects of metformin on seizures, cognitive impairment and brain oxidative stress markers observed in pentylenetetrazole-induced kindling animals. Male C57BL/6 mice were administered with subconvulsive dose of pentylenetetrazole (37 mg/kg, i.p.) every other day for 14 injections. Metformin was injected intraperitoneally in dose of 200mg/kg along with alternate-day PTZ. We found that metformin suppressed the progression of kindling, ameliorated the cognitive impairment and decreased brain oxidative stress. Thus the present study concluded that metformin may be a potential agent for the treatment of epilepsy as well as a protective medicine against cognitive impairment induced by seizures.


Subject(s)
Antioxidants/pharmacology , Kindling, Neurologic/drug effects , Metformin/pharmacology , Neuroprotective Agents/pharmacology , Animals , Brain/drug effects , Brain/metabolism , Brain/physiopathology , Convulsants/antagonists & inhibitors , Convulsants/toxicity , Glutathione/metabolism , Learning Disabilities/chemically induced , Learning Disabilities/physiopathology , Learning Disabilities/prevention & control , Male , Malondialdehyde/metabolism , Maze Learning/drug effects , Maze Learning/physiology , Memory Disorders/chemically induced , Memory Disorders/physiopathology , Memory Disorders/prevention & control , Mice , Mice, Inbred C57BL , Oxidative Stress/drug effects , Pentylenetetrazole/antagonists & inhibitors , Pentylenetetrazole/toxicity , Seizures/chemically induced , Seizures/physiopathology , Seizures/prevention & control
16.
Acta Pharmacol Sin ; 35(7): 869-78, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24858312

ABSTRACT

AIM: Potassium 2-(1-hydroxypentyl)-benzoate (dl-PHPB) is a new drug candidate for ischemic stroke. The aim of this study was to investigate the effects of dl-PHPB on memory deficits and long-term potentiation (LTP) impairment in animal models of Alzheimer's disease. METHODS: The expression of NMDA receptor subunits GluN1 and GluN2B in the hippocampus and cortex of APP/PS1 transgenic mice were detected using Western blot analysis. Memory deficits of the mice were evaluated with the passive avoidance test. LTP impairment was studied in the dentate region of Aß1-42-injected rats and APP/PS1 transgenic mice. RESULTS: APP/PS1 transgenic mice showed significantly lower levels of GluN1 and p-GluN2B in hippocampus, and chronic administration of dl-PHPB (100 mg · kg(-1) · d(-1), po) reversed the downregulation of p-GluN2B, but did not change GluN1 level in the hippocampus. Furthermore, chronic administration of dl-PHPB reversed the memory deficits in APP/PS1 transgenic mice. In the dentate region of normal rats, injection of dl-PHPB (100 µmol/L, icv) did not change the basal synaptic transmission, but significantly enhanced the high-frequency stimulation (HFS)-induced LTP, which was completely prevented by pre-injection of APV (150 µmol/L, icv). Chronic administration of dl-PHPB (100 mg · kg(-1) · d(-1), po) reversed LTP impairment in Aß1-42-injected normal rats and APP/PS1 transgenic mice. CONCLUSION: Chronic administration of dl-PHPB improves learning and memory and promotes LTP in the animal models of Alzheimer's disease, possibly via increasing p-GluN2B expression in the hippocampus.


Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/metabolism , Benzoates/pharmacology , Benzoic Acid/pharmacology , Long-Term Potentiation/drug effects , Memory Disorders/drug therapy , Pentanes/pharmacology , Peptide Fragments/metabolism , Alzheimer Disease/complications , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Amyloid beta-Protein Precursor/genetics , Animals , Disease Models, Animal , Male , Maze Learning , Memory/drug effects , Memory Disorders/complications , Memory Disorders/genetics , Memory Disorders/metabolism , Mice , Mice, Transgenic , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/metabolism
17.
Huan Jing Ke Xue ; 45(1): 459-469, 2024 Jan 08.
Article in Zh | MEDLINE | ID: mdl-38216495

ABSTRACT

Microplastic pollution is not only an environmental problem but also a social problem. Many studies have been conducted on the sources, abundance, and distribution of microplastics in the environment, but an understanding of human exposure levels and potential health risks remains very limited. Based on the bibliometric methods, the present review systematically summarized the exposure pathways of microplastics in humans, and then the characteristics and potential adverse impacts on human health were expounded upon. Available literature showed that microplastics in human bodies were mainly concentrated on sizes smaller than 50 µm, and polyethylene (PE), polypropylene (PP), and polyethylene terephthalate (PET) were the main polymers. Microplastics in environments entered human bodies mainly through food and respiratory pathways, then accumulated in lung and gastrointestinal tissues. Most importantly, small-sized microplastics could distribute in tissues and organs via the circulatory system. The results from lab-based toxicological experiments showed that microplastics not only posed threats to cell membrane integrity, immune stress, gut microbiota, and energy metabolism but also had potentially adverse impacts on the reproductive system. To further understand the health risks of microplastic pollution, it is necessary to promote research on the toxicological effects of microplastics as well as the inner mechanisms and also to establish risk assessment frameworks for evaluating microplastic pollution. These works are crucial to preventing the risks of microplastic pollution with scientific evidence.


Subject(s)
Microplastics , Water Pollutants, Chemical , Humans , Microplastics/toxicity , Plastics/adverse effects , Environmental Monitoring , Water Pollutants, Chemical/analysis , Environmental Pollution
18.
Ophthalmology ; 120(3): 489-494, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23177367

ABSTRACT

OBJECTIVE: To describe the development of flash visual evoked potentials (FVEPs) in preterm infants from 1 to 18 months and to determine if the maturation of FVEPs is similar to that of term infants. DESIGN: Longitudinal follow-up study. PARTICIPANTS: Twenty very low birth weight (VLBW) preterm infants, 42 low birth weight (LBW) preterm infants, and 41 term infants underwent FVEP recordings and neurodevelopmental examinations at 1, 3, 6, 9, 12, and 18 months of corrected and chronological ages. METHODS: The FVEP recordings were carried out with the VikingQuest-IV neuroelectrophysiological device (VikingQuest, Nicolet, WI), and neurodevelopmental assessments were made by the Development Screen Test and Bayley Scales of Infant Development, Second Edition. MAIN OUTCOME MEASURES: At 1, 3, 6, and 9 months of age, neurodevelopment was measured with the Mental Index and Developmental Quotient. At 12 and 18 months, neurodevelopment was assessed using the Mental Developmental Index and Psychomotor Developmental Index. Two FVEP values were analyzed: the P2 amplitude (peak to peak from the preceding N2 wave) and the latency of the P2 wave. RESULTS: There was no significant difference for age-dependent decreased pattern of FVEP P2 latency between preterm infants and the control group. This pattern consisted of a rapid decrease in the first 6 months of life, a gradual decline from 6 to 12 months of age, and a steady reduction from 12 to 18 months of age. The P2 latencies were prolonged significantly at all 6 recorded times in the VLBW group compared with the controls and showed a delay in the LBW group at 1 and 3 months of corrected age. The maturation of P2 latency in LBW infants is similar to that of the controls at 3 months of corrected age, but the maturation of P2 latency in VLBW children remained delayed when compared with the controls until 18 months of corrected age. CONCLUSIONS: Although the FVEP development pattern of preterm infants was similar to that of healthy full-term infants, the former had deficits in visual electrophysiologic maturation, especially for VLBW children.


Subject(s)
Developmental Disabilities/physiopathology , Evoked Potentials, Visual/physiology , Infant, Premature , Photic Stimulation , Retina/physiopathology , Vision Disorders/physiopathology , Vision, Ocular/physiology , Female , Follow-Up Studies , Gestational Age , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Infant, Very Low Birth Weight , Male , Prospective Studies , Retina/growth & development , Surveys and Questionnaires , Term Birth
19.
Dev Growth Differ ; 55(7): 676-86, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24020834

ABSTRACT

Insulin is a peptide hormone produced by beta cells of the pancreas. The roles of insulin in energy metabolism have been well studied, with most of the attention focused on glucose utilization, but the roles of insulin in cell proliferation and differentiation remain unclear. In this study, we observed for the first time that 10 nmol/L insulin treatment induces cell proliferation and cardiac differentiation of P19CL6 cells, whereas 50 and 100 nmol/L insulin treatment induces P19CL6 cell apoptosis and blocks cardiac differentiation of P19CL6 cells. By using real-time polymerase chain reaction (PCR) and Western blotting analysis, we found that the mRNA levels of cyclin D1 and α myosin heavy chain (α-MHC) are induced upon 10 nmol/L insulin stimulation and inhibited upon 50/100 nmol/L insulin treatment, whereas the mRNA levels of BCL-2-antagonist of cell death (BAD) exists a reverse trend. The similar results were observed in P19CL6 cells expressing GATA-6 or peroxisome proliferator-activated receptor α (PPARα). Our results identified the downstream targets of insulin, cyclin D1, BAD, α-MHC, and GATA-4, elucidate a novel molecular mechanism of insulin in promoting cell proliferation and differentiation.


Subject(s)
Cell Differentiation/drug effects , Cell Proliferation/drug effects , Insulin/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/genetics , Blotting, Western , Cell Differentiation/genetics , Cell Line, Tumor , Cyclin D1/genetics , Cyclin D1/metabolism , Dose-Response Relationship, Drug , Flow Cytometry , GATA4 Transcription Factor/genetics , GATA4 Transcription Factor/metabolism , GATA6 Transcription Factor/genetics , GATA6 Transcription Factor/metabolism , Gene Expression/drug effects , Mice , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Myosin Heavy Chains/genetics , Myosin Heavy Chains/metabolism , PPAR alpha/genetics , PPAR alpha/metabolism , Reverse Transcriptase Polymerase Chain Reaction , bcl-Associated Death Protein/genetics , bcl-Associated Death Protein/metabolism
20.
RNA Biol ; 10(4): 465-80, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23558708

ABSTRACT

GATA-4 is an important transcription factor involved in several developmental processes of the heart, such as cardiac myocyte proliferation, differentiation and survival. The precise mechanisms underlying the regulation of GATA-4 remain unclear, this is especially true for the mechanisms that mediate the post-transcriptional regulation of GATA-4. Here, we demonstrate that miR-200b, a member of the miR-200 family, is a critical regulator of GATA-4. Overexpression of miR-200b leads to the downregulation of GATA-4 mRNA and a decrease in GATA-4 protein levels. Moreover, miR-200b not only inhibits cell growth and differentiation but also reverses the growth response mediated by GATA-4, whereas depletion of miR-200b leads to a slight reversal of the anti-growth response achieved by knocking down endogenous GATA-4. More importantly, the cell cycle-associated gene cyclin D1, which is a downstream target of GATA-4, is also regulated by miR-200b. Thus, miR-200b targets GATA-4 to downregulate the expression of cyclin D1 and myosin heavy chain (MHC), thereby regulating cell growth and differentiation.


Subject(s)
Cell Cycle/genetics , GATA4 Transcription Factor/genetics , Gene Expression Regulation , MicroRNAs/metabolism , Animals , Apoptosis/genetics , Cell Cycle/physiology , Cell Cycle Checkpoints/genetics , Cell Differentiation/genetics , Cell Differentiation/physiology , Cell Line , Cell Line, Tumor , Cell Proliferation , Cyclin D1/genetics , Cyclin D1/metabolism , GATA4 Transcription Factor/metabolism , Humans , Mice , MicroRNAs/genetics , Muscle Development/genetics , Myocytes, Cardiac/metabolism , Myosin Heavy Chains/genetics , Myosin Heavy Chains/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL